# Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction

Study · id `cardio:ct-nct02913469` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02913469](<https://clinicaltrials.gov/study/NCT02913469>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02913469

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 128 participants.

## Technical summary

Registry record NCT02913469. Randomized; single masking; primary purpose treatment. Start 2014-12-12 (actual); primary completion 2020-08-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 128 participants (planned count; ClinicalTrials.gov record NCT02913469, source copy `cardio:ctgov-nct02913469-2020-03-31`, retrieved 2026-10-26)
- Started: 2014-12-12 (actual) (ClinicalTrials.gov record NCT02913469, source copy `cardio:ctgov-nct02913469-2020-03-31`, retrieved 2026-10-26)
- Primary completion: 2020-08-15 (anticipated) (ClinicalTrials.gov record NCT02913469, source copy `cardio:ctgov-nct02913469-2020-03-31`, retrieved 2026-10-26)
- Completion: 2020-08-15 (anticipated) (ClinicalTrials.gov record NCT02913469, source copy `cardio:ctgov-nct02913469-2020-03-31`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02913469, source copy `cardio:ctgov-nct02913469-2020-03-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02913469-2020-03-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
- Condition: ST-segment Elevation Myocardial Infarction
- Intervention (Drug): Morphine
- Intervention (Drug): metoclopramide
- Intervention (Drug): saline
- Lead sponsor: General Hospital of Chinese Armed Police Forces
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: General Hospital of Chinese Armed Police Forces (`cardio:org-general-hospital-of-chinese-armed-police-forces`)

## Provenance

Content hash: 66fd55e3d189af395b9cd6085d08bc93db06d13eb4abf0d00d7e06932b0c2d65
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
